| Code | CSB-RA004936MB15HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to MIL-97, targeting CD40, a transmembrane receptor protein belonging to the tumor necrosis factor receptor superfamily. CD40 plays a critical role in immune regulation by mediating interactions between antigen-presenting cells and T lymphocytes, facilitating B cell activation, immunoglobulin class switching, and memory cell formation. This receptor is expressed on various immune cells including B cells, dendritic cells, and macrophages, and its dysregulation has been implicated in autoimmune disorders, inflammatory diseases, and hematological malignancies. CD40 signaling also contributes to tumor immunity and has emerged as a therapeutic target in cancer immunotherapy.
MIL-97 is a reference antibody that has been utilized in research investigating CD40-mediated immune responses and therapeutic modulation. This biosimilar provides researchers with a reliable tool for studying CD40 biology, exploring immune cell interactions, investigating disease mechanisms, and evaluating potential therapeutic interventions in oncology and immunology research settings. The antibody supports investigations into checkpoint modulation and immune activation pathways.
There are currently no reviews for this product.